This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (1993)
- Inazawa, JP (2000 - 2003)
- Aichi, JP (2004)
Company Filing History:
Years Active: 1993-2004
Title: Nobutaka Oohata: Innovator in Cyclic Lipopeptide Research
Introduction
Nobutaka Oohata is a prominent inventor based in Inazawa, Japan. He has made significant contributions to the field of cyclic lipopeptide research, holding a total of 7 patents. His work has been instrumental in advancing the understanding and application of cyclic lipopeptides in various industries.
Latest Patents
Among his latest patents, Nobutaka Oohata has developed a process for the deacylation of cyclic lipopeptides. This innovative approach has the potential to enhance the efficacy of cyclic lipopeptides in pharmaceutical applications.
Career Highlights
Nobutaka Oohata is currently employed at Fujisawa Pharmaceutical Company, Ltd. His role at the company allows him to leverage his expertise in cyclic lipopeptide research, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Nobutaka has collaborated with notable colleagues, including Satoshi Ueda and Miho Tanaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Nobutaka Oohata's contributions to cyclic lipopeptide research and his innovative patents highlight his importance in the field. His work continues to influence the pharmaceutical industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile